BAFF stimulates and extends the life of B lymphocytes, which produce antibodies against foreign and self-protein. It was approved by the FDA in March 2011. Genetically engineered immune cells are also being studied in animal models of the disease as of 2019.In September 2022, researchers at the University of Erlangen-Nuremberg published promising results using genetically altered immune cells to treat severely ill patients. Four women and one man received transfusions of CAR T cells modified to attack their B cells, eliminating the aberrant ones. The therapy drove the disease into remission in all five patients, who have been off lupus medication for several months after the treatment ended. See also
Canine discoid lupus erythematosus in dogs
List of people with lupus

References
External links

Lupus at Curlie
Systemic Lupus Erythematosus at the National Institute of Arthritis and Musculoskeletal and Skin Diseases
Mannosidosis is a deficiency in mannosidase, an enzyme.There are two types:

Alpha-mannosidosis
Beta-mannosidosis

See also
Swainsonine


== References ==